- The Oncology Institute to Participate at Upcoming Investor Conferences
- The Oncology Institute Executives to Participate in Multiple Panel Presentations at APG 2024 Spring Conference
- The Oncology Institute Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Guidance
- The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit
- The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call
- Jordan McInerney Appointed as Chief Development Officer of The Oncology Institute
- The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California
- The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024
- MaxHealth & The Oncology Institute Expand Value-Based Care Partnership
- The Oncology Institute Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call
More ▼
Key statistics
On Thursday, Oncology Institute Inc (TOI:NAQ) closed at 0.4707, 12.61% above the 52 week low of 0.418 set on Jun 07, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.4699 |
---|---|
High | 0.50 |
Low | 0.455 |
Bid | 0.4505 |
Offer | 0.4898 |
Previous close | 0.4614 |
Average volume | 281.55k |
---|---|
Shares outstanding | 74.44m |
Free float | 50.85m |
P/E (TTM) | -- |
Market cap | 33.53m USD |
EPS (TTM) | -0.8066 USD |
Data delayed at least 15 minutes, as of May 30 2024 21:00 BST.
More ▼